Furthermore, many of its interactive targets have only recently been discovered.13 The S100A1-target complexes and their resulting functions, especially in modulating the TME and antitumor immunity and in potentiating cancer immunotherapy, have not yet been completely defined. This evidence concerns the gene S100A1 and cancer.